NOV 05, 2017 08:21 AM PST

Will Genetic Sequencing Become a Routine Part of Health Care?

WRITTEN BY: Carmen Leitch

While the information obtained from genetic testing is not useful for many healthcare decisions that patients and their doctors make today, it is likely to become a much bigger factor in the future. The more we reveal about the human genome, the more clinicians and patients will be able to make more tailored choices about health issues that may arise. The Geisinger Institute wants to improve healthcare, and they are trying to do it for as many people as possible with a new project.

An NHGRI researcher uses a pipette to remove DNA from a micro test tube. / Credit: Wikimedia Commons/Maggie Bartlett, NHGRI

As we reveal more about the genome, many new possibilities arise in preventive health care and patient-specific treatments. This issue will become more relevant to everyday medicine in the near future, as patients and doctors become more equipped to make choices about healthcare. One major concern is that not everyone will be able to benefit from these new possibilities and the better health they may afford. The Geisinger Institute is aiming to confront these issues.

The Danville, Pennsylvania-based Geisinger Health System has developed and run what is known as the MyCode Community Health Initiative. The project sequenced the exomes, or protein-coding regions of DNA, of over 92,400 people so far. More than 166,000 people have enrolled in the study; the ultimate goal is to recruit half a million patients from the 3.3 million that use Geisinger services. About 85% of the participants have also agreed to participate in the experimental program in which they receive their information, called GenomeFIRST Return of Results.

Geisinger wants, of course, to use the genetic data to prevent and treat disease, but they want to examine other questions as well. They are interested in how primary care physicians that may have very little knowledge of genetics are able to advise patients who have learned of disease-causing genetic mutations, and how the new information impacts family members who find out they might be at risk. This research will help doctors decide what is appropriate to reveal to people about their genomes. "This is the future of health care," commented Michael Snyder, the Director of Stanford Medicine's Center for Genomics and Personalized Medicine in Palo Alto, California. "Incorporating a person's genome sequence information into disease risk assessment is a no-brainer,” he told Science.

Patients find out if they carry a mutation in any of 76 genes, all of which have been conclusively linked to 27 disorders, like heart disease or breast cancer. The conditions are all treatable, said the Head of Clinical Genomics at Geisinger, Michael Murray. If a variant does not have an established, accepted treatment, the patient is not notified. It’s estimated that 3.5 percent of participants will learn they have a variant associated with disease. Their primary care physician is told first, and the physician gets more information about the variant and how to explain it to the patient. 

Some scientists have expressed concern that not enough information is disclosed. Other commend the restraint, because there are many variants we simply do not yet know enough about in order to tell people what it will really mean for their health.

Source: Science, Geisinger

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 20, 2018
Videos
NOV 20, 2018
A Major Grant Aims to Improve our Understanding of Age-related Cognitive Decline
The American Heart Association has teamed up with the Allen Initiative in Brain Health and Cognitive Impairment to award the Salk Institute $19.2 million....
NOV 20, 2018
Immunology
NOV 20, 2018
Mutations Mutations Which Ones Do We Want?
A team at UCSF makes use of new SLICE tool to generate mutations that reveal specific genetic functions....
NOV 23, 2018
Videos
NOV 23, 2018
Authorities Enlist DNA Experts to ID Camp Fire Victims
Paradise, California, a town of 26,682 residents, was destroyed by the Camp Fire earlier this month....
NOV 28, 2018
Immunology
NOV 28, 2018
Regulators to the Rescue
Scientists at Scripps Research Institute describe the nature of an immune regulator protein...
DEC 05, 2018
Videos
DEC 05, 2018
Promising Results From Early Trials of Gene Therapy for Sickle Cell Anemia
More than 90,000 Americans and millions of people around the world have SCA....
JAN 06, 2019
Genetics & Genomics
JAN 06, 2019
Exploring the Impact of Extensive Newborn Screening
While the exact number now varies by state, newborns are screened for several diseases. Should we be doing more?...
Loading Comments...